|
ZFP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.503850E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.928800E-01 |
| Normal-vs-Stage2 |
4.790800E-01 |
| Normal-vs-Stage3 |
3.377400E-03 |
| Normal-vs-Stage4 |
4.14859999999795E-05 |
| Stage1-vs-Stage2 |
2.230000E-01 |
| Stage1-vs-Stage3 |
3.69359999999874E-05 |
| Stage1-vs-Stage4 |
1.8799000001124E-07 |
| Stage2-vs-Stage3 |
2.621000E-01 |
| Stage2-vs-Stage4 |
4.968300E-02 |
| Stage3-vs-Stage4 |
1.790560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.938400E-01 |
| Normal-vs-AfricanAmerican |
4.631900E-02 |
| Normal-vs-Asian |
5.359600E-01 |
| Caucasian-vs-AfricanAmerican |
2.840600E-01 |
| Caucasian-vs-Asian |
4.237200E-01 |
| AfricanAmerican-vs-Asian |
1.772220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.111800E-02 |
| Normal-vs-Female |
5.550200E-01 |
| Male-vs-Female |
2.345800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.890400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.500800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.812100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.229730E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.091600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.594600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.012400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.585000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.014210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.638580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.703900E-02 |
| Normal-vs-Grade 2 |
2.214200E-01 |
| Normal-vs-Grade 3 |
9.580600E-03 |
| Normal-vs-Grade 4 |
2.41189999972136E-07 |
| Grade 1-vs-Grade 2 |
3.396400E-01 |
| Grade 1-vs-Grade 3 |
1.820240E-03 |
| Grade 1-vs-Grade 4 |
1.68033999999873E-05 |
| Grade 2-vs-Grade 3 |
4.97590000003711E-06 |
| Grade 2-vs-Grade 4 |
1.24010024471488E-10 |
| Grade 3-vs-Grade 4 |
7.411800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.901700E-02 |
| Normal-vs-ccB subtype |
1.117760E-02 |
| ccA subtype-vs-ccB subtype |
6.49209999981082E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.811360E-01 |
| Normal-vs-N1 |
1.698560E-03 |
| N0-vs-N1 |
4.387800E-02 |
|
|
